St. Vincent Medical Group, Inc.

Indianapolis, Indiana 46290

2 studies enrolling now · 20 studies all time

What they study most

AAA - Abdominal Aortic Aneurysm, Acute Myocardial Infarction, Aorta, Lesion, Aorta; Lesion, Aortic Aneurysm, Thoracic, Atrial Fibrillation, COVID, COVID-19, COVID19, Cardiovascular Diseases, Chronic Obstructive Pulmonary Disease, Combined Pulmonary Fibrosis and Emphysema

Studies at this site

• Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endoprosthesis or Iliac Branch Endoprosthesis — Recruiting now
• A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation — Running, not enrolling
• Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension — Running, not enrolling
• A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients — Completed
• Inhaled Treprostinil in Participants With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD) — Stopped early
• LOWER: Lomitapide Observational Worldwide Evaluation Registry — Completed
• Evaluation of the GORE® TBE Device in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta, Zone 2 — Running, not enrolling
• A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension — Enrolling by invitation
• Evaluation of the GORE® TBE Device in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta, Zone 0/1 — Running, not enrolling
• A Registry for Patients Taking Uptravi — Completed
• Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States — Completed
• PRE-VENT Study in Hospitalized Patients With Severe COVID-19 With or Without Cancer — Stopped early
• A Study in Participants With Sarcoidosis-associated Pulmonary Hypertension (SAPH) to Assess the Efficacy and Safety of Oral Selexipag — Stopped early
• A Phase 3 Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Participants With Pulmonary Hypertension (PH) Due to Chronic Obstructive Pulmonary Disease (COPD) — Stopped early
• CONVERGE - Epi/Endo Ablation For Treatment of Persistent Atrial Fibrillation(AF) — Completed
• IK-5001 for the Prevention of Remodeling of the Ventricle and Congestive Heart Failure After Acute Myocardial Infarction — Completed
• Study of Evinacumab (REGN1500) in Participants With Persistent Hypercholesterolemia — Completed
• An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE — Stopped early
• Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE — Completed
• An Efficacy and Safety Study of Ixmyelocel-T in Patients With Critical Limb Ischemia (CLI) — Completed